Skip to main content
Clinical Trials/CTRI/2023/11/059458
CTRI/2023/11/059458
Not yet recruiting
Phase 2

Single Blind Randomized Study to Evaluate Efficacy of Solanium Lycopersicum in Comparison with Individualized Homoeopathic Medicines in Cases of Allergic Rhinitis - NI

Parul University0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Sponsor
Parul University
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \>Newly diagnosed and pre\-diagnosed cases of Allergic Rhinitis.
  • \>Diagnosed cases of Allergic Rhinitis who have taken medicines from any other system of treatment like Allopathy, Ayurvedic, etc. will also be considered after a washout period of 15 days.
  • \>Patients who have previously taken Homoeopathy medicines prior to the visit were also taken into consideration after 1 month of washout period.
  • \>The patients who have given their consent to participate in study with follow ups.

Exclusion Criteria

  • \>The cases which did not fulfil the inclusion criteria.
  • \>Patient having Allergic Rhinitis in association with other autoimmune disorders.
  • \>Patients with other respiratory diseases and other systemic illness (Diabetes Mellitus, Metabolic Syndrome, Cardiovascular diseases, Endometrial neoplasia) etc. Rhinitis secondary to anatomical abnormalities or any other complications.
  • \>Pregnant women and lactating mothers.
  • \>Patients not giving written consent.
  • \>Cases with irregular follow up.

Outcomes

Primary Outcomes

Not specified

Similar Trials